LISA CAFFEE: Open Payments
NPI 1548706807 · ROYAL OAK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,083 in 23 payments from 14 companies in 2025. Trend: 2023 $1,179 · 2024 $1,807 · 2025 $2,083
Food & beverage: $1,971Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $500 |
| ABBVIE INC. | 5 | $489 |
| JAZZ PHARMACEUTICALS INC. | 1 | $125 |
| Madrigal Pharmaceuticals | 1 | $124 |
| MDD US Operations, LLC | 1 | $117 |
| Neurocrine BioSciences, Inc. | 1 | $117 |
| Stryker Corporation | 1 | $116 |
| Ipsen Biopharmaceuticals, Inc | 1 | $91 |
| GENZYME CORPORATION | 1 | $89 |
| SK Life Science, Inc. | 1 | $75 |
Products named: AUSTEDO XR, VRAYLAR, XYWAV, REZDIFFRA, INGREZZA, FLOWTRIEVER CATHETER, S, UBRELVY, IQIRVO.
Industry payments across MI — which companies pay providers there.
